Crystal structure of 1,1 -(1,3-propanediyl)bis(4-cyano)pyridiniuiii dibromide, [NC-C5H4N-C3H6-NC5H4-CN]Br2

по Inkmann E., Holzgrabe U., Schröder D., Reuter H.
Опубликовано 1997-12-01

New Semiphysiological Absorption Model To Assess the Pharmacodynamic Profile of Cefuroxime Axetil Using Nonparametric and Parametric Population Pharmacokinetics

по Bulitta, J. B., Landersdorfer, C. B., Kinzig, M., Holzgrabe, U., Sorgel, F.
Опубликовано 2009

Emerging Antimicrobial Drug Resistance in Africa and Latin America: Search for Reasons

по Hoellein L, Kaale E, Hebron Mwalwisi Y, Schulze MH, Vetye-Maler C, Holzgrabe U
Опубликовано 2022-04-01

Comparable Population Pharmacokinetics and Pharmacodynamic Breakpoints of Cefpirome in Cystic Fibrosis Patients and Healthy Volunteers

по Bulitta, J. B., Kinzig, M., Landersdorfer, C. B., Holzgrabe, U., Stephan, U., Sörgel, F.
Опубликовано 2011

Systematic Comparison of the Population Pharmacokinetics and Pharmacodynamics of Piperacillin in Cystic Fibrosis Patients and Healthy Volunteers

по Bulitta, J. B., Duffull, S. B., Kinzig-Schippers, M., Holzgrabe, U., Stephan, U., Drusano, G. L., Sörgel, F.
Опубликовано 2007

Population Pharmacokinetic Comparison and Pharmacodynamic Breakpoints of Ceftazidime in Cystic Fibrosis Patients and Healthy Volunteers

по Bulitta, J. B., Landersdorfer, C. B., Hüttner, S. J., Drusano, G. L., Kinzig, M., Holzgrabe, U., Stephan, U., Sörgel, F.
Опубликовано 2010

Agonists with supraphysiological efficacy at the muscarinic M(2) ACh receptor

по Schrage, R, Seemann, WK, Klöckner, J, Dallanoce, C, Racké, K, Kostenis, E, De Amici, M, Holzgrabe, U, Mohr, K
Опубликовано 2013